Company intelligence / Profile preview

HC Capital

Shanghai, Shanghai, Chinahccapital.com.cn ↗

Ownership: Private
Development stage: Other

Overview

HC Capital (also known as HaoCheng Capital) is a leading healthcare-focused private equity and venture capital firm based in China. Founded in 2015, the firm specializes in investments across the entire healthcare value chain, including biotechnology, medical devices, pharmaceutical services, and healthcare providers. HC Capital is known for its deep industry expertise and has built a robust portfolio of over 100 companies, many of which have become leaders in the Chinese and global life sciences markets. The firm provides strategic support and capital to high-growth companies aiming to address significant unmet medical needs through innovation.

Industry: Investors

Beyond the preview

Go deeper on HC Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HC Capital.

Explore the full profile